Clinical Trial Update: COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer [Phase 4]

View source ↗

Summary

This clinical trial update shows the COACTION trial evaluating combination androgen blockade in intermediate to high-risk prostate cancer is in Phase 4 and curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Brazilian Clinical Research Institute | Conditions: Prostate Cancer | Phase 4 | Status: ACTIVE_NOT_RECRUITING